Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs XP Inc. Class A Common Stock (XP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs XP Inc. Class A Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.32 (market cap $2.27B), while XP Inc. Class A Common Stock trades at $30.23 (market cap $15.33B). The key difference: XP Inc. Class A Common Stock is far larger — about 6.8× SELLAS Life Sciences Group Inc. Common Stock's market cap, and XP Inc. Class A Common Stock pays a 0.66% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | XP | |
|---|---|---|
Market Cap | $2.27B | $15.33B |
Volume | 4,179,659 | 14,214,379 |
Sector | Health | Financials |
52-Week High | $15.46 | $30.21 |
52-Week Low | $1.39 | $14.94 |
Enterprise Value | $2.14B | $24.96B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 0.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About XP Inc. Class A Common Stock
XP Inc. provides investment products and financial services in Brazil. Its platform includes brokerage, investment funds, fixed-income products, banking, insurance, and retirement solutions.
Read more on XP →
